Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free TRAK Stock Alerts

ReposiTrak (TRAK) Financials

ReposiTrak logo
$8.56 -0.14 (-1.61%)
As of 09:30 AM Eastern
Compare
Annual Income Statements for ReposiTrak

Annual Income Statements for ReposiTrak

This table shows ReposiTrak's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -6.56 -0.06 2.99 2.84 3.32 1.01 3.53 3.42 5.00 5.41 6.62
Consolidated Net Income / (Loss)		 -3.85 0.67 3.78 3.41 3.90 1.59 4.12 4.00 5.59 5.96 6.98
Net Income / (Loss) Continuing Operations		 -3.85 0.67 3.78 3.41 3.90 1.59 4.12 4.00 5.59 5.96 6.98
Total Pre-Tax Income 		-3.85 0.67 3.89 3.51 4.05 1.64 4.19 4.13 5.91 6.33 7.65
Total Operating Income		 -4.09 0.69 3.90 3.52 3.99 1.48 2.89 4.41 5.09 5.02 6.23
Total Gross Profit		 8.39 9.73 14 15 15 13 14 15 16 17 19
Total Revenue		 14 14 19 22 21 20 21 18 19 20 23
Operating Revenue		 14 14 19 22 21 20 21 18 19 20 23
Total Cost of Revenue		 5.26 4.28 5.32 6.59 5.83 7.00 6.88 3.19 3.31 3.42 3.68
Operating Cost of Revenue		 5.26 4.28 5.32 6.59 5.83 7.00 6.88 3.19 3.31 3.42 3.68
Total Operating Expenses		 12 9.04 9.72 12 11 12 11 10 11 12 13
Selling, General & Admin Expense		 4.28 3.17 4.14 4.89 4.74 4.95 5.21 4.72 4.69 5.33 5.60
Marketing Expense		 5.94 5.37 5.10 6.40 6.01 5.78 5.00 4.85 4.93 5.49 5.84
Depreciation Expense		 0.77 0.51 0.49 0.63 0.60 0.84 1.02 0.88 1.08 1.19 1.25
Total Other Income / (Expense), net		 0.24 -0.02 -0.02 -0.00 0.06 0.16 1.30 -0.28 0.82 1.34 1.37
Interest & Investment Income		 0.00 -0.03 0.01 0.16 0.10 0.22 0.30 0.20 0.82 1.27 1.38
Other Income / (Expense), net		 - - - - - 0.00 1.11 -0.44 0.06 0.06 -0.02
Income Tax Expense		 0.00 0.00 0.11 0.11 0.14 0.04 0.08 0.13 0.32 0.37 0.68
Preferred Stock Dividends Declared		 2.71 0.73 0.79 0.57 0.59 0.59 0.59 0.59 0.59 0.55 0.36
Basic Earnings per Share		 ($0.38) $0.00 $0.15 $0.14 $0.17 $0.05 $0.18 $0.18 $0.27 $0.30 $0.36
Weighted Average Basic Shares Outstanding		 17.38M 19.15M 19.35M 19.58M 19.85M 19.65M 19.50M 19.09M 18.41M 18.20M 18.26M
Diluted Earnings per Share		 ($0.38) $0.00 $0.15 $0.14 $0.16 $0.05 $0.18 $0.18 $0.27 $0.29 $0.35
Weighted Average Diluted Shares Outstanding		 17.38M 19.15M 20.26M 20.28M 20.37M 19.86M 19.75M 19.38M 18.77M 18.93M 19.14M

Quarterly Income Statements for ReposiTrak

This table shows ReposiTrak's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.23 1.30 1.42 1.46 1.56 1.46 1.88 1.73 1.76 1.64 1.95
Consolidated Net Income / (Loss)		 1.38 1.45 1.55 1.58 1.67 1.55 1.97 1.80 1.82 1.69 1.99
Net Income / (Loss) Continuing Operations		 1.38 1.45 1.55 1.58 1.67 1.55 1.97 1.80 1.82 1.69 1.99
Total Pre-Tax Income 		1.48 1.57 1.61 1.68 1.82 1.70 2.12 2.02 2.27 2.14 2.44
Total Operating Income		 1.20 1.24 1.26 1.32 1.48 1.35 1.81 1.59 1.89 1.82 2.25
Total Gross Profit		 4.29 4.15 4.25 4.34 4.58 4.49 5.00 4.85 5.12 5.00 5.08
Total Revenue		 5.06 5.13 5.08 5.18 5.44 5.49 5.91 5.76 5.97 5.86 5.88
Operating Revenue		 5.06 5.13 5.08 5.18 5.44 5.49 5.91 5.76 5.97 5.86 5.88
Total Cost of Revenue		 0.77 0.97 0.83 0.84 0.86 1.00 0.91 0.91 0.85 0.85 0.80
Operating Cost of Revenue		 0.77 0.97 0.83 0.84 0.86 1.00 0.91 0.91 0.85 0.85 0.80
Total Operating Expenses		 3.09 2.91 2.99 3.02 3.10 3.14 3.19 3.27 3.22 3.19 2.83
Selling, General & Admin Expense		 1.28 1.35 1.35 1.35 1.29 1.38 1.46 1.48 1.37 1.47 1.38
Marketing Expense		 1.51 1.26 1.35 1.37 1.53 1.46 1.41 1.45 1.61 1.49 1.36
Depreciation Expense		 0.31 0.30 0.29 0.29 0.28 0.30 0.33 0.34 0.24 0.22 0.10
Total Other Income / (Expense), net		 0.29 0.33 0.36 0.36 0.35 0.36 0.32 0.34 0.39 0.33 0.19
Interest & Investment Income		 0.26 0.32 0.35 0.35 0.35 0.35 0.33 0.35 0.36 0.40 0.32
Other Income / (Expense), net		 0.03 0.02 0.01 0.02 -0.00 0.01 -0.01 -0.02 0.02 -0.07 -0.13
Income Tax Expense		 0.10 0.11 0.06 0.10 0.15 0.15 0.15 0.22 0.45 0.45 0.45
Preferred Stock Dividends Declared		 0.15 0.15 0.13 0.12 0.11 0.10 0.09 0.07 0.06 0.05 0.03
Basic Earnings per Share		 $0.07 $0.07 $0.08 $0.08 $0.09 $0.08 $0.10 $0.09 $0.10 $0.09 $0.11
Weighted Average Basic Shares Outstanding		 18.23M 18.16M 18.19M 18.20M 18.24M 18.25M 18.25M 18.26M 18.29M 18.27M 18.21M
Diluted Earnings per Share		 $0.07 $0.07 $0.08 $0.07 $0.08 $0.08 $0.10 $0.09 $0.09 $0.09 $0.10
Weighted Average Diluted Shares Outstanding		 18.84M 18.81M 18.95M 18.93M 19.10M 19.14M 19.14M 19.14M 19.13M 19.05M 18.84M
Weighted Average Basic & Diluted Shares Outstanding		 - 18.21M 18.22M 0.00 18.26M 18.27M 18.28M 0.00 18.29M 18.20M 18.17M

Annual Cash Flow Statements for ReposiTrak

This table details how cash moves in and out of ReposiTrak's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 7.97 0.12 2.61 0.84 3.72 1.74 3.72 -2.61 2.53 1.16 3.41
Net Cash From Operating Activities		 1.71 0.50 2.26 2.18 4.58 4.20 5.40 6.10 8.86 6.96 8.42
Net Cash From Continuing Operating Activities		 0.92 4.18 8.75 7.90 4.58 4.20 5.40 6.10 8.86 6.96 8.42
Net Income / (Loss) Continuing Operations		 -3.85 0.67 3.78 3.41 3.90 1.59 4.12 4.00 5.59 5.96 6.98
Consolidated Net Income / (Loss)		 -3.85 0.67 3.78 3.41 3.90 1.59 4.12 4.00 5.59 5.96 6.98
Depreciation Expense		 0.77 0.51 0.49 0.63 0.60 0.80 1.02 0.88 1.08 1.19 1.25
Amortization Expense		 - - - - 0.00 0.08 0.09 0.33 0.06 0.06 0.06
Non-Cash Adjustments To Reconcile Net Income		 4.60 1.10 1.60 1.05 1.06 1.20 0.28 1.13 1.69 0.74 1.18
Changes in Operating Assets and Liabilities, net		 0.19 -1.78 -3.61 -2.92 -0.99 0.52 -0.10 -0.23 0.44 -0.99 -1.05
Net Cash From Investing Activities		 -2.61 -0.37 -1.95 -0.32 -0.97 -0.65 -0.32 1.32 -0.90 -0.10 0.00
Net Cash From Continuing Investing Activities		 -2.61 -0.37 -1.95 -0.32 -0.97 -0.65 -0.32 1.32 -0.90 -0.10 0.00
Purchase of Property, Plant & Equipment		 -0.37 -0.26 -1.96 -0.32 -1.45 -0.65 -0.32 -0.05 -0.90 -0.07 -0.02
Sale and/or Maturity of Investments		 0.30 4.61 - 0.00 0.48 - - - - -0.03 0.02
Net Cash From Financing Activities		 8.87 -0.02 2.30 -1.03 0.11 -1.81 -1.36 -10 -5.43 -5.70 -5.01
Net Cash From Continuing Financing Activities		 8.87 -0.02 2.30 -1.03 0.11 -1.81 -1.36 -10 -5.43 -5.70 -5.01
Repayment of Debt		 -0.25 -0.24 -0.24 -0.59 -1.83 -0.30 -0.92 0.00 -0.20 -0.21 -0.36
Repurchase of Preferred Equity		 -0.01 0.00 0.00 -1.00 - - - - - -2.37 -3.00
Repurchase of Common Equity		 - - - 0.00 -0.48 -2.16 -1.31 -6.15 -1.31 -1.52 -0.20
Payment of Dividends		 -0.16 -0.01 -0.01 -0.78 -0.44 -0.59 -0.59 -0.59 -1.41 -1.72 -1.66
Other Financing Activities, net		 0.00 0.03 0.16 0.67 0.16 - 0.12 0.11 0.09 0.11 0.21
Cash Interest Paid		 0.08 0.05 0.02 0.17 0.15 0.02 0.10 0.05 0.06 0.02 0.02
Cash Income Taxes Paid		 0.00 0.00 0.07 0.08 0.08 0.10 0.17 0.19 0.30 0.33 0.44

Quarterly Cash Flow Statements for ReposiTrak

This table details how cash moves in and out of ReposiTrak's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.29 -0.44 1.20 0.70 0.64 2.25 0.09 0.43 0.23 -0.09 -2.30
Net Cash From Operating Activities		 1.52 0.93 2.46 2.05 1.87 3.46 1.43 1.66 1.54 2.24 2.08
Net Cash From Continuing Operating Activities		 1.52 0.93 2.46 2.05 1.87 3.46 1.43 1.66 1.54 2.24 2.08
Net Income / (Loss) Continuing Operations		 1.38 1.45 1.55 1.58 1.67 1.55 1.97 1.80 1.82 1.69 1.99
Consolidated Net Income / (Loss)		 1.38 1.45 1.55 1.58 1.67 1.55 1.97 1.80 1.82 1.69 1.99
Depreciation Expense		 0.31 0.30 0.29 0.29 0.28 0.30 0.33 0.34 0.24 0.22 0.10
Non-Cash Adjustments To Reconcile Net Income		 0.16 0.16 0.16 0.26 0.25 0.25 0.25 0.43 0.33 0.38 0.30
Changes in Operating Assets and Liabilities, net		 -0.34 -1.00 0.44 -0.09 -0.34 1.34 -1.13 -0.92 -0.85 -0.05 -0.29
Net Cash From Investing Activities		 0.00 -0.02 -0.03 -0.05 0.03 -0.02 -0.01 -0.01 -0.02 0.00 -3.03
Net Cash From Continuing Investing Activities		 0.00 -0.02 -0.03 -0.05 0.03 -0.02 -0.01 -0.01 -0.02 0.00 -3.03
Other Investing Activities, net		 - - - - 0.03 -0.02 -0.02 - -0.01 0.00 -2.99
Net Cash From Financing Activities		 -1.81 -1.36 -1.23 -1.30 -1.27 -1.19 -1.33 -1.22 -1.29 -2.33 -1.35
Net Cash From Continuing Financing Activities		 -1.81 -1.36 -1.23 -1.30 -1.27 -1.19 -1.33 -1.22 -1.29 -2.33 -1.35
Repayment of Debt		 -0.13 0.00 -0.08 0.00 -0.15 -0.02 -0.14 -0.05 -0.05 -0.05 -0.05
Repurchase of Preferred Equity		 0.00 -0.75 -0.75 -0.87 -0.75 -0.75 -0.75 -0.75 -0.75 -0.75 -0.38
Repurchase of Common Equity		 -1.32 -0.19 - - 0.00 -0.10 - -0.10 -0.15 -1.10 -0.55
Payment of Dividends		 -0.42 -0.42 -0.45 -0.44 -0.42 -0.41 -0.51 -0.31 -0.40 -0.42 -0.41
Other Financing Activities, net		 0.06 - 0.05 - 0.06 0.08 0.07 0.00 0.06 - 0.04
Cash Interest Paid		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Cash Income Taxes Paid		 0.22 0.10 - 0.01 0.31 0.06 - 0.06 0.54 0.17 0.00

Annual Balance Sheets for ReposiTrak

This table presents ReposiTrak's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 36 39 46 49 53 53 55 49 51 52 55
Total Current Assets		 13 15 19 24 27 27 30 27 27 29 34
Cash & Equivalents		 11 11 14 15 19 20 24 21 24 25 29
Accounts Receivable		 1.64 3.05 4.01 4.22 3.88 4.01 3.89 3.17 2.52 3.68 4.13
Prepaid Expenses		 0.46 0.39 0.64 1.12 1.04 0.50 0.49 1.31 0.57 0.29 0.56
Other Current Assets		 - - - 3.50 3.02 2.30 1.25 0.65 0.19 0.18 0.43
Plant, Property, & Equipment, net		 0.76 0.47 2.12 1.90 2.97 3.00 2.59 0.76 0.99 0.51 0.60
Total Noncurrent Assets		 22 23 25 24 23 23 23 22 22 22 21
Noncurrent Note & Lease Receivables		 - - - - - - - - - - 0.00
Goodwill		 21 21 21 21 21 21 21 21 21 21 21
Intangible Assets		 1.31 1.37 1.19 1.09 0.86 0.68 0.70 0.51 0.96 0.52 0.13
Other Noncurrent Operating Assets		 0.01 0.99 3.02 1.69 1.68 1.72 1.17 0.58 0.48 0.38 0.03
Total Liabilities & Shareholders' Equity		 36 39 46 49 53 53 55 49 51 52 55
Total Liabilities		 8.82 8.09 10 9.59 9.72 11 9.91 6.42 4.70 4.74 5.81
Total Current Liabilities		 8.40 7.54 8.17 7.99 8.80 8.91 9.30 6.10 4.23 4.54 5.53
Short-Term Debt		 2.73 2.74 3.17 3.42 4.96 5.45 6.00 2.59 0.22 0.22 0.23
Accounts Payable		 0.82 0.58 0.57 1.49 0.53 0.41 0.47 0.69 0.43 0.27 0.28
Accrued Expenses		 2.52 1.50 2.08 0.75 1.40 1.12 0.99 1.21 1.62 1.55 1.84
Current Deferred Revenue		 2.33 2.72 2.35 2.34 1.92 1.85 1.76 1.56 1.90 2.44 3.18
Total Noncurrent Liabilities		 0.42 0.55 2.03 1.60 0.92 1.94 0.61 0.32 0.47 0.20 0.28
Long-Term Debt		 0.42 0.55 2.03 1.60 0.92 1.24 - 0.00 0.21 0.00 0.28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 28 31 36 40 43 43 45 43 46 47 50
Total Preferred & Common Equity		 28 31 36 40 43 43 45 43 46 47 50
Preferred Stock		 - - - - 0.01 0.01 - 0.01 0.01 0.01 0.00
Total Common Equity		 28 30 36 40 43 43 45 43 46 47 50
Common Stock		 70 73 76 77 77 75 74 69 68 65 62
Retained Earnings		 -43 -43 -40 -37 -34 -33 -29 -26 -22 -18 -13
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - - 0.00 -0.03 -0.01

Quarterly Balance Sheets for ReposiTrak

This table presents ReposiTrak's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 50 50 51 52 55 55 56 56 57
Total Current Assets		 27 28 29 30 32 33 34 35 33
Cash & Equivalents		 24 23 24 26 28 28 29 29 26
Accounts Receivable		 3.02 3.80 3.78 3.30 3.37 3.60 4.34 4.85 5.10
Prepaid Expenses		 0.32 0.37 0.45 0.33 0.33 0.41 0.74 0.93 1.14
Other Current Assets		 0.16 0.15 0.15 0.67 0.65 0.61 0.24 0.48 0.45
Plant, Property, & Equipment, net		 0.84 0.72 0.59 0.68 0.89 0.75 0.52 0.43 0.36
Total Noncurrent Assets		 22 22 22 22 21 21 21 21 24
Noncurrent Note & Lease Receivables		 - - - - - - - - 3.00
Goodwill		 21 21 21 21 21 21 21 21 21
Intangible Assets		 0.85 0.74 0.63 0.42 0.32 0.23 0.06 0.00 0.00
Other Noncurrent Operating Assets		 0.45 0.42 0.40 0.26 0.24 0.23 0.03 0.03 0.03
Total Liabilities & Shareholders' Equity		 50 50 51 52 55 55 56 56 57
Total Liabilities		 4.61 4.59 4.86 4.81 6.80 5.91 5.44 6.59 6.88
Total Current Liabilities		 4.28 4.27 4.64 4.46 6.25 5.43 5.21 6.42 6.77
Short-Term Debt		 0.21 0.22 0.22 0.19 0.32 0.23 0.23 0.23 0.23
Accounts Payable		 0.31 0.33 0.51 0.33 0.29 0.29 0.31 0.19 0.27
Accrued Expenses		 1.61 1.63 1.39 1.29 1.42 1.17 1.99 2.35 2.51
Current Deferred Revenue		 2.08 2.03 2.47 2.59 4.16 3.68 2.69 3.65 3.75
Total Noncurrent Liabilities		 0.33 0.32 0.22 0.35 0.55 0.48 0.23 0.17 0.11
Long-Term Debt		 0.08 0.08 0.00 0.17 0.38 0.33 0.23 0.17 0.11
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 46 46 46 48 48 49 50 50 50
Total Preferred & Common Equity		 46 46 46 48 48 49 50 50 50
Preferred Stock		 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 46 46 46 48 48 49 50 50 50
Common Stock		 67 66 65 64 64 63 62 60 59
Retained Earnings		 -21 -20 -19 -17 -16 -14 -11 -10 -8.70
Accumulated Other Comprehensive Income / (Loss)		 - -0.01 -0.03 0.01 -0.01 -0.01 -0.02 -0.02 -0.05

Annual Metrics And Ratios for ReposiTrak

This table displays calculated financial ratios and metrics derived from ReposiTrak's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding		 17,996,618.00 19,220,051.00 19,412,911.00 19,766,486.00 19,871,283.00 19,459,538.00 19,478,037.00 18,596,308.00 18,355,898.00 18,223,893.00 18,276,380.00
DEI Adjusted Shares Outstanding		 17,996,618.00 19,220,051.00 19,412,911.00 19,766,486.00 19,871,283.00 19,459,538.00 19,478,037.00 18,596,308.00 18,355,898.00 18,223,893.00 18,276,380.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.36 0.00 0.15 0.14 0.17 0.05 0.18 0.18 0.27 0.30 0.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 14.42% 2.65% 35.18% 16.35% -3.93% -5.35% 4.84% -14.09% 5.83% 7.09% 10.53%
EBITDA Growth		 -94.01% 135.94% 267.16% -5.39% 10.60% -48.53% 116.16% 1.44% 21.38% 0.79% 18.72%
EBIT Growth		 -57.84% 116.80% 467.49% -9.85% 13.43% -62.95% 170.75% -0.59% 29.48% -1.22% 22.04%
NOPAT Growth		 -57.84% 124.00% 451.77% -10.06% 12.82% -62.58% 97.16% 50.59% 12.58% -1.80% 20.10%
Net Income Growth		 -54.60% 117.31% 466.77% -9.76% 14.48% -59.17% 158.42% -2.78% 39.65% 6.58% 17.12%
EPS Growth		 -100.00% 100.00% 0.00% -6.67% 14.29% -68.75% 260.00% 0.00% 50.00% 7.41% 20.69%
Operating Cash Flow Growth		 1,945.37% -70.53% 348.54% -3.44% 110.09% -8.36% 28.73% 12.95% 45.21% -21.40% 20.90%
Free Cash Flow Firm Growth		 -485.84% 82.80% 68.10% 161.19% 628.01% -6.23% 56.80% 55.70% -10.70% -21.53% 19.73%
Invested Capital Growth		 110.88% 15.12% 20.18% 11.07% 2.19% -5.10% -6.42% -11.22% -7.14% -1.78% -2.09%
Revenue Q/Q Growth		 3.02% 2.57% 7.94% 5.42% -7.29% 5.87% -5.33% -0.04% 1.20% 3.64% 2.62%
EBITDA Q/Q Growth		 -137.06% 171.15% 10.62% 10.43% -17.78% 14.75% 56.99% -8.01% 8.69% 1.57% 3.87%
EBIT Q/Q Growth		 -88.90% 130.35% 11.31% 12.68% -20.34% 15.64% 81.49% -8.97% 8.26% 2.30% 3.92%
NOPAT Q/Q Growth		 -88.90% 143.35% 11.09% 12.52% -20.50% 16.30% 30.51% -0.50% 0.69% 1.24% 3.00%
Net Income Q/Q Growth		 -97.11% 130.10% 11.37% 12.80% -21.80% 22.96% 20.02% -1.73% 5.29% 5.21% 3.22%
EPS Q/Q Growth		 -35.71% 100.00% 25.00% 7.69% -27.27% 66.67% 28.57% 0.00% 8.00% 3.57% 6.06%
Operating Cash Flow Q/Q Growth		 51.35% -64.08% -0.15% 5.17% 17.75% 24.54% 2.46% 0.29% -3.01% 3.87% -4.50%
Free Cash Flow Firm Q/Q Growth		 -438.71% 82.22% -235.00% 141.61% -0.02% 116.81% 0.29% 2.69% -76.76% 132.08% -4.11%
Invested Capital Q/Q Growth		 81.06% 2.61% 8.91% 3.77% 0.30% -4.37% -2.42% -3.55% 1,301.54% -1.42% 0.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 61.49% 69.45% 71.92% 70.11% 72.46% 65.08% 67.23% 82.34% 82.67% 83.30% 83.72%
EBITDA Margin		 -24.36% 8.53% 23.16% 18.84% 21.69% 11.79% 24.31% 28.71% 32.93% 30.99% 33.29%
Operating Margin		 -29.98% 4.91% 20.60% 15.96% 18.84% 7.38% 13.77% 24.46% 26.65% 24.56% 27.55%
EBIT Margin		 -29.98% 4.91% 20.60% 15.96% 18.84% 7.38% 19.05% 22.04% 26.97% 24.88% 27.47%
Profit (Net Income) Margin		 -28.21% 4.76% 19.95% 15.47% 18.43% 7.95% 19.60% 22.18% 29.27% 29.13% 30.87%
Tax Burden Percent		 100.00% 100.00% 97.23% 97.00% 96.47% 97.44% 98.17% 96.86% 94.56% 94.09% 91.17%
Interest Burden Percent		 94.07% 96.95% 99.59% 99.92% 101.40% 110.63% 104.81% 103.89% 114.77% 124.46% 123.26%
Effective Tax Rate		 0.00% 0.00% 2.77% 3.00% 3.53% 2.56% 1.83% 3.14% 5.44% 5.91% 8.83%
Return on Invested Capital (ROIC)		 -20.02% 3.29% 15.42% 12.04% 12.76% 4.85% 10.14% 16.73% 20.77% 21.37% 26.18%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.53% 3.55% 15.60% 12.06% 12.29% 3.69% 2.08% 18.21% 17.11% 16.30% 21.27%
Return on Net Nonoperating Assets (RNNOA)		 -0.13% -1.00% -4.01% -3.00% -3.35% -1.13% -0.75% -7.64% -8.18% -8.52% -11.69%
Return on Equity (ROE)		 -20.15% 2.29% 11.41% 9.04% 9.41% 3.71% 9.39% 9.09% 12.59% 12.85% 14.48%
Cash Return on Invested Capital (CROIC)		 -91.36% -10.77% -2.92% 1.55% 10.59% 10.08% 16.78% 28.62% 28.18% 23.17% 28.29%
Operating Return on Assets (OROA)		 -15.34% 1.83% 9.23% 7.39% 7.80% 2.78% 7.38% 7.62% 10.31% 9.96% 11.61%
Return on Assets (ROA)		 -14.43% 1.78% 8.94% 7.16% 7.63% 3.00% 7.59% 7.67% 11.19% 11.66% 13.05%
Return on Common Equity (ROCE)		 -20.15% 2.29% 11.41% 9.04% 9.41% 3.71% 9.39% 9.09% 12.59% 12.85% 14.48%
Return on Equity Simple (ROE_SIMPLE)		 -13.96% 2.19% 10.58% 8.59% 9.03% 3.74% 9.12% 9.33% 12.18% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.86 0.69 3.79 3.41 3.85 1.44 2.84 4.28 4.81 4.73 5.68
NOPAT Margin		 -20.99% 4.91% 20.03% 15.48% 18.18% 7.19% 13.52% 23.69% 25.20% 23.11% 25.11%
Net Nonoperating Expense Percent (NNEP)		 -20.55% -0.26% -0.18% -0.03% 0.48% 1.16% 8.06% -1.48% 3.66% 5.08% 4.91%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 10.04% 11.35%
Cost of Revenue to Revenue		 38.51% 30.55% 28.08% 29.89% 27.54% 34.92% 32.77% 17.66% 17.33% 16.70% 16.28%
SG&A Expenses to Revenue		 31.36% 22.59% 21.84% 22.21% 22.40% 24.70% 24.82% 26.13% 24.53% 26.06% 24.78%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 91.47% 64.55% 51.32% 54.15% 53.62% 57.70% 53.46% 57.88% 56.02% 58.73% 56.17%
Earnings before Interest and Taxes (EBIT)		 -4.09 0.69 3.90 3.52 3.99 1.48 4.00 3.98 5.15 5.09 6.21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.32 1.19 4.39 4.15 4.59 2.36 5.11 5.18 6.29 6.34 7.52
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.97 5.57 6.51 3.88 2.43 1.91 2.34 1.88 4.01 5.93 7.25
Price to Tangible Book Value (P/TBV)		 40.84 20.60 17.05 8.68 4.89 3.86 4.49 3.75 7.66 10.91 12.60
Price to Revenue (P/Rev)		 16.10 12.12 12.27 6.98 4.96 4.05 5.03 4.47 9.64 13.58 15.89
Price to Earnings (P/E)		 0.00 0.00 77.81 54.26 31.65 80.56 29.95 23.60 36.78 51.34 54.27
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.60% 0.42% 0.36%
Earnings Yield		 0.00% 0.00% 1.29% 1.84% 3.16% 1.24% 3.34% 4.24% 2.72% 1.95% 1.84%
Enterprise Value to Invested Capital (EV/IC)		 10.90 7.24 8.32 4.83 3.03 2.33 3.24 2.57 7.19 11.53 15.43
Enterprise Value to Revenue (EV/Rev)		 15.50 11.54 11.80 6.53 4.36 3.37 4.17 3.42 8.40 12.36 14.65
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 135.34 50.96 34.69 20.09 28.55 17.17 11.92 25.52 39.87 44.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 235.24 57.30 40.94 23.12 45.64 21.91 15.52 31.16 49.67 53.32
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 235.24 58.94 42.21 23.96 46.84 30.88 14.44 33.34 53.46 58.32
Enterprise Value to Operating Cash Flow (EV/OCF)		 123.88 321.36 99.04 66.06 20.14 16.08 16.23 10.12 18.11 36.29 39.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 328.13 28.87 22.52 18.67 8.44 24.58 49.31 53.96
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.11 0.11 0.15 0.13 0.14 0.16 0.13 0.06 0.01 0.00 0.01
Long-Term Debt to Equity		 0.02 0.02 0.06 0.04 0.02 0.03 0.00 0.00 0.00 0.00 0.01
Financial Leverage		 -0.25 -0.28 -0.26 -0.25 -0.27 -0.31 -0.36 -0.42 -0.48 -0.52 -0.55
Leverage Ratio		 1.40 1.29 1.28 1.26 1.23 1.24 1.24 1.19 1.13 1.10 1.11
Compound Leverage Factor		 1.31 1.25 1.27 1.26 1.25 1.37 1.30 1.23 1.29 1.37 1.37
Debt to Total Capital		 10.25% 9.73% 12.72% 11.22% 11.97% 13.58% 11.73% 5.70% 0.92% 0.46% 1.02%
Short-Term Debt to Total Capital		 8.87% 8.11% 7.75% 7.64% 10.09% 11.06% 11.73% 5.70% 0.47% 0.46% 0.46%
Long-Term Debt to Total Capital		 1.38% 1.62% 4.97% 3.58% 1.88% 2.52% 0.00% 0.00% 0.44% 0.00% 0.56%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.00% 0.02% 0.02% 0.01% 0.01%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 89.72% 90.25% 87.26% 88.76% 88.01% 86.41% 88.25% 94.29% 99.06% 99.52% 98.97%
Debt to EBITDA		 -0.95 2.75 1.19 1.21 1.28 2.83 1.17 0.50 0.07 0.03 0.07
Net Debt to EBITDA		 2.46 -6.83 -2.02 -2.38 -2.77 -5.78 -3.54 -3.64 -3.75 -3.93 -3.73
Long-Term Debt to EBITDA		 -0.13 0.46 0.46 0.39 0.20 0.52 0.00 0.00 0.03 0.00 0.04
Debt to NOPAT		 -1.10 4.78 1.37 1.47 1.53 4.65 2.11 0.61 0.09 0.05 0.09
Net Debt to NOPAT		 2.85 -11.86 -2.33 -2.89 -3.31 -9.48 -6.36 -4.41 -4.90 -5.28 -4.94
Long-Term Debt to NOPAT		 -0.15 0.80 0.54 0.47 0.24 0.86 0.00 0.00 0.04 0.00 0.05
Altman Z-Score		 13.46 11.69 13.42 9.64 6.63 4.50 6.72 7.93 24.14 35.94 38.15
Noncontrolling Interest Sharing Ratio		 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.60 1.97 2.29 2.97 3.02 3.05 3.19 4.36 6.44 6.45 6.09
Quick Ratio		 1.54 1.92 2.21 2.39 2.55 2.73 3.01 4.04 6.26 6.35 5.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -13 -2.25 -0.72 0.44 3.19 3.00 4.70 7.31 6.53 5.12 6.14
Operating Cash Flow to CapEx		 462.09% 190.67% 116.08% 691.36% 316.25% 645.14% 1,694.03% 0.00% 980.97% 9,499.03% 52,741.20%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -27.16 2.63 74.84 44.23 44.03 165.06 107.08 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 85.47 13.06 107.27 61.95 50.64 137.71 145.27 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 11.84 11.17 73.35 52.35 47.65 167.58 130.46 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.51 0.37 0.45 0.46 0.41 0.38 0.39 0.35 0.38 0.40 0.42
Accounts Receivable Turnover		 6.07 5.98 5.37 5.35 5.23 5.08 5.32 5.11 6.72 6.60 5.79
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 18.14 22.71 14.66 10.99 8.70 6.71 7.51 10.76 21.82 27.28 40.53
Accounts Payable Turnover		 6.76 6.13 9.28 6.41 5.77 14.92 15.74 5.50 5.90 9.81 13.45
Days Sales Outstanding (DSO)		 60.15 61.08 68.01 68.17 69.84 71.82 68.62 71.36 54.35 55.34 63.06
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 54.00 59.59 39.32 56.96 63.26 24.46 23.19 66.31 61.88 37.20 27.13
Cash Conversion Cycle (CCC)		 6.15 1.49 28.69 11.21 6.58 47.36 45.44 5.06 -7.52 18.13 35.94
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 19 22 27 30 30 29 27 24 22 22 21
Invested Capital Turnover		 0.95 0.67 0.77 0.78 0.70 0.67 0.75 0.71 0.82 0.92 1.04
Increase / (Decrease) in Invested Capital		 10 2.94 4.51 2.97 0.65 -1.56 -1.86 -3.04 -1.72 -0.40 -0.46
Enterprise Value (EV)		 212 162 224 144 92 67 88 62 160 253 331
Market Capitalization		 220 170 232 154 105 81 106 81 184 278 359
Book Value per Share		 $1.53 $1.59 $1.84 $2.01 $2.17 $2.19 $2.32 $2.31 $2.50 $2.57 $2.71
Tangible Book Value per Share		 $0.30 $0.43 $0.70 $0.90 $1.08 $1.08 $1.21 $1.16 $1.31 $1.40 $1.56
Total Capital		 31 34 41 45 49 49 51 45 46 47 50
Total Debt		 3.15 3.29 5.20 5.02 5.88 6.69 6.00 2.59 0.43 0.22 0.51
Total Long-Term Debt		 0.42 0.55 2.03 1.60 0.92 1.24 0.00 0.00 0.21 0.00 0.28
Net Debt		 -8.17 -8.16 -8.85 -9.87 -13 -14 -18 -19 -24 -25 -28
Capital Expenditures (CapEx)		 0.37 0.26 1.94 0.32 1.45 0.65 0.32 -1.32 0.90 0.07 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -3.57 -1.36 -0.35 4.27 4.09 3.34 2.33 1.62 -0.73 -0.18 -0.18
Debt-free Net Working Capital (DFNWC)		 7.76 10 14 19 23 24 26 23 23 25 28
Net Working Capital (NWC)		 5.03 7.35 11 16 18 18 20 20 23 25 28
Net Nonoperating Expense (NNE)		 0.99 0.02 0.02 0.00 -0.05 -0.15 -1.28 0.27 -0.78 -1.23 -1.30
Net Nonoperating Obligations (NNO)		 -8.17 -8.16 -8.85 -9.87 -13 -14 -18 -19 -24 -25 -28
Total Depreciation and Amortization (D&A)		 0.77 0.51 0.49 0.63 0.60 0.88 1.11 1.20 1.14 1.25 1.32
Debt-free, Cash-free Net Working Capital to Revenue		 -26.13% -9.69% -1.84% 19.38% 19.33% 16.68% 11.09% 8.95% -3.82% -0.87% -0.81%
Debt-free Net Working Capital to Revenue		 56.85% 71.99% 72.37% 86.96% 107.24% 118.21% 125.68% 127.87% 121.79% 122.11% 125.57%
Net Working Capital to Revenue		 36.87% 52.44% 55.63% 71.44% 83.83% 91.01% 97.11% 113.51% 120.65% 121.04% 124.54%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.38) $0.00 $0.15 $0.14 $0.17 $0.05 $0.18 $0.18 $0.27 $0.30 $0.36
Adjusted Weighted Average Basic Shares Outstanding		 19.06M 19.29M 19.35M 19.58M 19.85M 19.65M 19.50M 19.09M 18.41M 18.20M 18.26M
Adjusted Diluted Earnings per Share		 ($0.38) $0.00 $0.15 $0.14 $0.16 $0.05 $0.18 $0.18 $0.27 $0.29 $0.35
Adjusted Weighted Average Diluted Shares Outstanding		 19.06M 19.29M 20.26M 20.28M 20.37M 19.86M 19.75M 19.38M 18.77M 18.93M 19.14M
Adjusted Basic & Diluted Earnings per Share		 ($0.38) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 17.38M 19.15M 19.42M 19.79M 19.82M 19.50M 19.40M 18.47M 18.18M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -1.82 0.48 3.79 3.41 3.85 1.44 2.84 4.28 4.81 4.73 5.68
Normalized NOPAT Margin		 -13.32% 3.43% 20.03% 15.48% 18.18% 7.19% 13.52% 23.69% 25.20% 23.11% 25.11%
Pre Tax Income Margin		 -28.21% 4.76% 20.51% 15.95% 19.11% 8.16% 19.97% 22.90% 30.95% 30.96% 33.86%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 147.73 21.07 93.46 21.82 37.51 89.79 84.45 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 143.64 20.44 90.16 21.26 26.62 96.50 78.93 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 74.10 19.18 59.54 12.22 34.52 119.65 69.65 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 70.01 18.55 56.24 11.66 23.63 126.37 64.12 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -4.08% 1.59% 0.28% 22.94% 11.27% 36.81% 14.24% 14.65% 25.31% 28.90% 23.74%
Augmented Payout Ratio		 -4.08% 1.59% 0.28% 22.94% 23.63% 172.28% 46.02% 168.23% 48.73% 54.33% 26.60%

Quarterly Metrics And Ratios for ReposiTrak

This table displays calculated financial ratios and metrics derived from ReposiTrak's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 18,175,480.00 18,158,205.00 18,209,501.00 18,223,893.00 18,246,089.00 18,260,982.00 18,271,702.00 18,276,380.00 18,283,903.00 18,288,455.00 18,203,410.00
DEI Adjusted Shares Outstanding		 18,175,480.00 18,158,205.00 18,209,501.00 18,223,893.00 18,246,089.00 18,260,982.00 18,271,702.00 18,276,380.00 18,283,903.00 18,288,455.00 18,203,410.00
DEI Earnings Per Adjusted Shares Outstanding		 0.07 0.07 0.08 0.08 0.09 0.08 0.10 0.09 0.10 0.09 0.11
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.19% 7.90% 5.41% 16.09% 7.53% 7.12% 16.30% 11.15% 9.75% 6.66% -0.52%
EBITDA Growth		 -3.93% 13.24% -16.28% 6.35% 14.22% 6.99% 36.61% 17.07% 21.99% 17.30% 3.31%
EBIT Growth		 -4.92% 9.80% -18.57% 9.35% 20.26% 8.30% 42.15% 17.50% 29.93% 28.47% 17.78%
NOPAT Growth		 -4.67% 2.51% -12.46% 4.19% 21.39% 7.03% 38.29% 13.53% 11.83% 16.47% 9.20%
Net Income Growth		 7.27% 14.68% -6.77% 22.97% 20.79% 6.89% 26.79% 13.81% 9.27% 8.70% 1.01%
EPS Growth		 16.67% 16.67% 0.00% 16.67% 14.29% 14.29% 25.00% 28.57% 12.50% 12.50% 0.00%
Operating Cash Flow Growth		 -16.05% -37.44% -34.71% 14.47% 22.89% 271.54% -41.65% -19.33% -17.68% -35.31% 45.22%
Free Cash Flow Firm Growth		 210.89% -1,096.69% -178.61% -43.63% -188.85% 118.10% 113.22% 13.96% 108.56% -82.18% -148.68%
Invested Capital Growth		 0.00% 742.63% 1,296.47% -1.78% 0.00% -9.63% -3.99% -2.09% -1.16% 4.00% 14.45%
Revenue Q/Q Growth		 13.35% 1.30% -0.80% 1.92% 4.99% 0.91% 7.70% -2.59% 3.67% -1.92% 0.45%
EBITDA Q/Q Growth		 0.31% 1.31% 0.02% 4.63% 7.74% -5.11% 27.71% -10.34% 12.27% -8.76% 12.48%
EBIT Q/Q Growth		 0.37% 2.37% 0.91% 5.46% 10.38% -7.81% 32.45% -12.83% 22.06% -8.84% 21.43%
NOPAT Q/Q Growth		 -6.20% 2.86% 5.64% 2.22% 9.29% -9.31% 36.49% -16.08% 7.65% -5.55% 27.97%
Net Income Q/Q Growth		 7.42% 5.27% 6.84% 1.79% 5.51% -6.85% 26.74% -8.63% 1.30% -7.34% 17.77%
EPS Q/Q Growth		 16.67% 0.00% 14.29% -12.50% 14.29% 0.00% 25.00% -10.00% 0.00% 0.00% 11.11%
Operating Cash Flow Q/Q Growth		 -15.24% -38.77% 164.05% -16.48% -9.00% 85.12% -58.53% 15.47% -7.14% 45.49% -6.91%
Free Cash Flow Firm Q/Q Growth		 702.05% -181.15% -2.61% 108.44% -1,364.14% 116.53% -25.08% -27.21% -5.03% -65.59% -304.64%
Invested Capital Q/Q Growth		 -100.00% 0.00% -2.43% -1.42% 0.78% -6.77% 3.66% 0.52% 1.73% -1.90% 14.08%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 84.86% 81.01% 83.64% 83.70% 84.21% 81.74% 84.58% 84.24% 85.70% 85.42% 86.35%
EBITDA Margin		 30.65% 30.65% 30.91% 31.73% 32.56% 30.62% 36.30% 33.42% 36.19% 33.67% 37.70%
Operating Margin		 23.72% 24.21% 24.83% 25.49% 27.20% 24.62% 30.59% 27.54% 31.72% 31.02% 38.27%
EBIT Margin		 24.25% 24.51% 24.93% 25.80% 27.12% 24.78% 30.47% 27.27% 32.11% 29.84% 36.08%
Profit (Net Income) Margin		 27.24% 28.31% 30.49% 30.45% 30.60% 28.25% 33.24% 31.18% 30.47% 28.79% 33.75%
Tax Burden Percent		 93.21% 92.71% 96.27% 94.04% 91.74% 91.07% 92.91% 88.92% 80.17% 78.93% 81.52%
Interest Burden Percent		 120.52% 124.59% 127.03% 125.52% 123.00% 125.18% 117.40% 128.58% 118.36% 122.20% 114.75%
Effective Tax Rate		 6.79% 7.29% 3.73% 5.96% 8.26% 8.93% 7.09% 11.08% 19.83% 21.07% 18.48%
Return on Invested Capital (ROIC)		 0.00% 34.29% 39.59% 22.17% 47.07% 21.92% 28.73% 25.52% 26.79% 27.40% 31.99%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 33.36% 38.60% 20.78% 44.66% 20.64% 27.63% 24.06% 25.67% 26.49% 31.43%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -23.91% -28.57% -10.87% -23.90% -11.08% -15.00% -13.23% -14.13% -15.09% -16.95%
Return on Equity (ROE)		 0.00% 10.38% 11.02% 11.30% 23.17% 10.83% 13.72% 12.29% 12.66% 12.30% 15.03%
Cash Return on Invested Capital (CROIC)		 0.00% -119.59% -134.08% 23.17% -155.03% 33.39% 29.36% 28.29% 27.77% 24.86% 13.64%
Operating Return on Assets (OROA)		 0.00% 9.63% 9.75% 10.33% 10.80% 10.00% 12.65% 11.53% 13.77% 12.63% 15.09%
Return on Assets (ROA)		 0.00% 11.12% 11.93% 12.19% 12.18% 11.40% 13.79% 13.18% 13.06% 12.19% 14.12%
Return on Common Equity (ROCE)		 0.00% 10.38% 11.02% 11.30% 23.17% 10.83% 13.72% 12.29% 12.66% 12.30% 15.03%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 12.63% 12.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.12 1.15 1.22 1.24 1.36 1.23 1.68 1.41 1.52 1.43 1.84
NOPAT Margin		 22.10% 22.44% 23.90% 23.97% 24.95% 22.42% 28.42% 24.49% 25.43% 24.49% 31.20%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.93% 0.99% 1.38% 2.42% 1.27% 1.10% 1.46% 1.12% 0.91% 0.56%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.50% 2.60% 2.64% 2.84% 2.53% 3.40% 2.82% 3.00% 2.86% 3.61%
Cost of Revenue to Revenue		 15.14% 18.99% 16.36% 16.30% 15.79% 18.26% 15.42% 15.76% 14.30% 14.58% 13.66%
SG&A Expenses to Revenue		 25.28% 26.28% 26.59% 26.08% 23.76% 25.07% 24.61% 25.66% 22.98% 25.06% 23.39%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 61.14% 56.80% 58.81% 58.21% 57.01% 57.12% 54.00% 56.70% 53.98% 54.40% 48.08%
Earnings before Interest and Taxes (EBIT)		 1.23 1.26 1.27 1.34 1.48 1.36 1.80 1.57 1.92 1.75 2.12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1.55 1.57 1.57 1.64 1.77 1.68 2.15 1.93 2.16 1.97 2.22
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 3.96 6.19 5.93 7.06 8.39 7.52 7.25 5.40 4.55 2.74
Price to Tangible Book Value (P/TBV)		 0.00 7.51 11.52 10.91 12.81 15.05 13.23 12.60 9.27 7.85 4.67
Price to Revenue (P/Rev)		 8.15 9.30 14.57 13.58 16.11 18.97 16.71 15.89 11.71 9.63 5.89
Price to Earnings (P/E)		 31.09 34.89 56.50 51.34 58.55 68.35 57.96 54.27 39.72 32.29 19.55
Dividend Yield		 0.86% 0.77% 0.40% 0.42% 0.36% 0.31% 0.34% 0.36% 0.50% 0.62% 1.03%
Earnings Yield		 3.22% 2.87% 1.77% 1.95% 1.71% 1.46% 1.73% 1.84% 2.52% 3.10% 5.12%
Enterprise Value to Invested Capital (EV/IC)		 0.00 6.94 11.84 11.53 14.05 18.20 15.95 15.43 11.11 9.24 4.60
Enterprise Value to Revenue (EV/Rev)		 0.00 8.12 13.34 12.36 14.89 17.68 15.45 14.65 10.49 8.42 4.78
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 24.16 42.20 39.87 47.31 56.22 46.99 44.00 30.66 24.12 13.57
Enterprise Value to EBIT (EV/EBIT)		 0.00 30.04 52.94 49.67 58.14 68.90 56.97 53.32 36.48 28.12 15.26
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 32.66 56.39 53.46 62.47 74.27 61.76 58.32 41.53 32.74 18.09
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 19.73 39.27 36.29 42.43 38.10 38.61 39.32 29.99 28.82 14.94
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 49.31 0.00 51.76 53.20 53.96 39.79 37.90 35.96
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00
Financial Leverage		 0.00 -0.72 -0.74 -0.52 -0.54 -0.54 -0.54 -0.55 -0.55 -0.57 -0.54
Leverage Ratio		 0.00 1.10 1.10 1.10 1.10 1.12 1.11 1.11 1.10 1.14 1.13
Compound Leverage Factor		 0.00 1.37 1.40 1.38 1.35 1.40 1.31 1.43 1.31 1.39 1.30
Debt to Total Capital		 0.00% 0.65% 0.46% 0.46% 0.74% 1.44% 1.14% 1.02% 0.90% 0.81% 0.69%
Short-Term Debt to Total Capital		 0.00% 0.47% 0.46% 0.46% 0.39% 0.65% 0.47% 0.46% 0.46% 0.47% 0.46%
Long-Term Debt to Total Capital		 0.00% 0.18% 0.00% 0.00% 0.35% 0.79% 0.67% 0.56% 0.44% 0.34% 0.23%
Preferred Equity to Total Capital		 0.00% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 99.33% 99.52% 99.52% 99.25% 98.55% 98.86% 98.97% 99.09% 99.19% 99.31%
Debt to EBITDA		 0.00 0.05 0.03 0.03 0.05 0.11 0.08 0.07 0.06 0.05 0.04
Net Debt to EBITDA		 0.00 -3.51 -3.88 -3.93 -3.88 -4.10 -3.81 -3.73 -3.58 -3.45 -3.15
Long-Term Debt to EBITDA		 0.00 0.01 0.00 0.00 0.03 0.06 0.05 0.04 0.03 0.02 0.01
Debt to NOPAT		 0.00 0.06 0.05 0.05 0.07 0.14 0.10 0.09 0.08 0.07 0.06
Net Debt to NOPAT		 0.00 -4.74 -5.19 -5.28 -5.12 -5.42 -5.00 -4.94 -4.85 -4.68 -4.20
Long-Term Debt to NOPAT		 0.00 0.02 0.00 0.00 0.03 0.08 0.06 0.05 0.04 0.03 0.02
Altman Z-Score		 0.00 24.15 36.01 35.70 42.55 36.12 38.08 37.88 30.75 21.47 12.93
Noncontrolling Interest Sharing Ratio		 0.00% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 6.45 6.21 6.45 6.75 5.18 6.03 6.09 6.54 5.45 4.89
Quick Ratio		 0.00 6.33 6.08 6.35 6.53 5.02 5.84 5.91 6.35 5.23 4.66
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 23 -19 -19 1.64 -21 3.43 2.57 1.87 1.77 0.61 -1.25
Operating Cash Flow to CapEx		 0.00% 0.00% 35,080.53% 3,681.38% 0.00% 0.00% 16,313.14% 23,106.85% 13,093.17% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.39 0.39 0.40 0.40 0.40 0.42 0.42 0.43 0.42 0.42
Accounts Receivable Turnover		 0.00 5.88 6.56 6.60 6.32 5.91 5.97 5.79 6.06 5.71 5.39
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 20.81 22.95 27.28 30.83 26.33 32.93 40.53 38.73 35.50 42.32
Accounts Payable Turnover		 0.00 9.46 7.65 9.81 10.58 11.34 9.08 13.45 11.46 14.66 12.28
Days Sales Outstanding (DSO)		 0.00 62.10 55.66 55.34 57.78 61.76 61.12 63.06 60.25 63.90 67.66
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 38.57 47.73 37.20 34.51 32.19 40.21 27.13 31.84 24.89 29.73
Cash Conversion Cycle (CCC)		 0.00 23.53 7.93 18.13 23.27 29.57 20.91 35.94 28.41 39.01 37.93
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 23 22 22 22 21 21 21 22 21 24
Invested Capital Turnover		 0.00 1.53 1.66 0.92 1.89 0.98 1.01 1.04 1.05 1.12 1.03
Increase / (Decrease) in Invested Capital		 -22 20 21 -0.40 22 -2.20 -0.89 -0.46 -0.26 0.82 3.09
Enterprise Value (EV)		 0.00 158 263 253 310 375 340 331 243 198 112
Market Capitalization		 158 181 288 278 336 402 368 359 271 226 138
Book Value per Share		 $0.00 $2.52 $2.55 $2.57 $2.61 $2.62 $2.68 $2.71 $2.74 $2.72 $2.77
Tangible Book Value per Share		 $0.00 $1.33 $1.37 $1.40 $1.44 $1.46 $1.52 $1.56 $1.60 $1.58 $1.63
Total Capital		 0.00 46 47 47 48 49 49 50 51 50 51
Total Debt		 0.00 0.30 0.22 0.22 0.35 0.70 0.56 0.51 0.46 0.40 0.35
Total Long-Term Debt		 0.00 0.08 0.00 0.00 0.17 0.38 0.33 0.28 0.23 0.17 0.11
Net Debt		 0.00 -23 -24 -25 -25 -27 -28 -28 -28 -28 -26
Capital Expenditures (CapEx)		 0.00 0.00 0.01 0.06 0.00 0.00 0.01 0.01 0.01 -0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.26 -0.05 -0.18 0.03 -1.58 -0.59 -0.18 0.34 0.08 0.16
Debt-free Net Working Capital (DFNWC)		 0.00 24 24 25 26 26 28 28 29 29 27
Net Working Capital (NWC)		 0.00 23 24 25 26 26 27 28 29 29 26
Net Nonoperating Expense (NNE)		 -0.26 -0.30 -0.34 -0.34 -0.31 -0.32 -0.29 -0.39 -0.30 -0.25 -0.15
Net Nonoperating Obligations (NNO)		 0.00 -23 -24 -25 -25 -27 -28 -28 -28 -28 -26
Total Depreciation and Amortization (D&A)		 0.32 0.31 0.30 0.31 0.30 0.32 0.34 0.35 0.24 0.22 0.10
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 1.34% -0.28% -0.87% 0.16% -7.47% -2.66% -0.81% 1.46% 0.32% 0.69%
Debt-free Net Working Capital to Revenue		 0.00% 120.75% 123.63% 122.11% 123.94% 124.81% 125.06% 125.57% 125.91% 122.47% 113.20%
Net Working Capital to Revenue		 0.00% 119.64% 122.54% 121.04% 123.04% 123.31% 124.01% 124.54% 124.91% 121.47% 112.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.07 $0.08 $0.08 $0.09 $0.08 $0.10 $0.09 $0.10 $0.09 $0.11
Adjusted Weighted Average Basic Shares Outstanding		 0.00 18.16M 18.19M 18.20M 18.24M 18.25M 18.25M 18.26M 18.29M 18.27M 18.21M
Adjusted Diluted Earnings per Share		 $0.00 $0.07 $0.08 $0.07 $0.08 $0.08 $0.10 $0.09 $0.09 $0.09 $0.10
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 18.81M 18.95M 18.93M 19.10M 19.14M 19.14M 19.14M 19.13M 19.05M 18.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 18.21M 18.22M 0.00 18.26M 18.27M 18.28M 0.00 18.29M 18.20M 18.17M
Normalized Net Operating Profit after Tax (NOPAT)		 1.12 1.15 1.22 1.24 1.36 1.23 1.68 1.41 1.52 1.43 1.84
Normalized NOPAT Margin		 22.10% 22.44% 23.90% 23.97% 24.95% 22.42% 28.42% 24.49% 25.43% 24.49% 31.20%
Pre Tax Income Margin		 29.23% 30.54% 31.67% 32.38% 33.36% 31.02% 35.78% 35.07% 38.01% 36.47% 41.40%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 29.73% 29.17% 30.17% 28.90% 27.60% 27.00% 26.29% 23.74% 22.94% 22.73% 21.30%
Augmented Payout Ratio		 74.20% 68.52% 62.72% 54.33% 30.69% 28.58% 27.77% 26.60% 27.85% 41.29% 47.35%

Financials Breakdown Chart

Key Financial Trends

ReposiTrak’s latest quarter showed another profitable result, but cash flow and balance sheet trends were mixed. In Q3 2026, revenue grew modestly year over year, profitability remained solid, and the company continued to produce strong operating cash flow. However, cash declined sharply during the quarter because of heavy financing outflows, including dividends and share repurchases. Over the last four years, the business has generally shown stable sales, consistent profitability, and a very cash-rich balance sheet, but recent quarterly trends suggest growth has slowed and capital returns are consuming a meaningful amount of cash.

  • Revenue has held relatively steady with a slight upward drift over time. Q3 2026 revenue was $5.88 million, up from $5.08 million in Q3 2024 and roughly in line with recent quarters.
  • ReposiTrak continues to generate consistent profits. Q3 2026 net income was $1.99 million, compared with $1.96 million in Q3 2025 and $1.38 million in Q1 2024.
  • Operating cash flow remains strong. The company produced $2.08 million in operating cash flow in Q3 2026, showing the core business is still converting earnings into cash.
  • Gross margins appear strong and relatively stable. Q3 2026 gross profit was $5.08 million on $5.88 million of revenue, leaving a very high gross margin profile.
  • The balance sheet remains cash-heavy. As of Q3 2026, ReposiTrak had $26.4 million in cash and equivalents versus only $6.9 million in total liabilities.
  • Debt remains modest. Total debt was just $349,462 in Q3 2026, which is small relative to cash and equity.
  • Shareholder returns are a visible priority. The company consistently repurchased preferred and common equity and paid dividends over the last several quarters.
  • Interest income is still contributing meaningfully to pre-tax earnings. In Q3 2026, interest and investment income was $321,109, which is a helpful cushion to operating profit.
  • Receivables have risen alongside revenue. Accounts receivable increased to $5.10 million in Q3 2026 from $3.60 million in Q3 2025, which may simply reflect business growth, but it is worth watching.
  • Cash declined sharply in Q3 2026. Cash and equivalents fell by $2.30 million during the quarter, driven mainly by financing outflows.
  • Share repurchases and dividends are consuming a lot of cash. In Q3 2026, the company spent about $1.34 million on financing outflows after operating and investing activities.
  • Operating margins have softened from earlier periods. Revenue has been fairly flat, while marketing and SG&A remain large relative to sales.
  • Marketing expense remains elevated. In Q3 2026, marketing expense was $1.36 million, a substantial portion of revenue.
  • There was no major step-up in top-line growth. Quarterly revenue has stayed in a narrow range around $5.4 million to $5.9 million over the past year, suggesting slower growth rather than acceleration.

Bottom line: ReposiTrak looks financially sound, profitable, and well-capitalized, with very limited debt and strong recurring cash generation. The main investor takeaway is that the company’s operating business is stable, but growth is modest and capital returns are reducing cash balances. For retail investors, this looks more like a steady, cash-generating small-cap than a fast-growing compounder.

07/21/26 08:53 AM ETAI Generated. May Contain Errors.

ReposiTrak Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ReposiTrak's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

ReposiTrak's net income appears to be on an upward trend, with a most recent value of $6.98 million in 2025, falling from -$3.85 million in 2015. The previous period was $5.96 million in 2024. Find out what analysts predict for ReposiTrak in the coming months.

ReposiTrak's total operating income in 2025 was $6.23 million, based on the following breakdown:
  • Total Gross Profit: $18.92 million
  • Total Operating Expenses: $12.70 million

Over the last 10 years, ReposiTrak's total revenue changed from $13.65 million in 2015 to $22.61 million in 2025, a change of 65.6%.

ReposiTrak's total liabilities were at $5.81 million at the end of 2025, a 22.5% increase from 2024, and a 34.1% decrease since 2015.

In the past 10 years, ReposiTrak's cash and equivalents has ranged from $11.33 million in 2015 to $28.57 million in 2025, and is currently $28.57 million as of their latest financial filing in 2025.

Over the last 10 years, ReposiTrak's book value per share changed from 1.53 in 2015 to 2.71 in 2025, a change of 76.8%.


Related Companies

Financial statements for NYSE:TRAK last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...
Porter & Company | Sponsoredtc pixel
Elon Is Quietly Doubling Down on This Bizarre Asset
Yahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...
Brownstone Research | Sponsoredtc pixel